Ftd Companies Stock News

Buy FTD

*Your capital is at risk

$0.0040

+0 (+0%)

At Close: Apr 15, 2020

AviadoBio Announces First Patient Treated in ASPIRE-FTD Clinical Trial Evaluating AVB-101 for Frontotemporal Dementia with GRN Mutations

07:00am, Monday, 15'th Apr 2024

LONDON--(BUSINESS WIRE)--AviadoBio, a pioneering gene therapy company dedicated to developing and delivering potentially transformative medicines for neurodegenerative disorders, today announced that

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by